Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) — Net Asset Quality Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a Net Asset Quality Index of 79.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $3.00 Billion minus total liabilities of $614.48 Million yields net assets of $2.39 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Shanghai Shenqi Pharmaceutical Investmen asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Net Asset Quality Index Over Time (2015–2024)
This chart shows how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B's Net Asset Quality Index has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the index stands at 79.5%, representing net assets of $2.39 Billion against total assets of $3.00 Billion USD. See Shanghai Shenqi Pharmaceutical Investmen (900904) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)
The table below presents the year-by-year Net Asset Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B from 2015 to 2024, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 900904 company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 77.9% | $2.43 Billion | $3.12 Billion | $689.01 Million | ▲ +5.0 pp |
| 2023 | 72.9% | $2.39 Billion | $3.28 Billion | $888.77 Million | ▲ +2.9 pp |
| 2022 | 70.0% | $2.37 Billion | $3.39 Billion | $1.01 Billion | ▼ -5.9 pp |
| 2021 | 76.0% | $2.39 Billion | $3.15 Billion | $756.45 Million | ▲ +0.8 pp |
| 2020 | 75.1% | $2.33 Billion | $3.10 Billion | $770.28 Million | ▲ +0.3 pp |
| 2019 | 74.8% | $2.66 Billion | $3.56 Billion | $894.60 Million | ▼ -8.3 pp |
| 2018 | 83.1% | $2.60 Billion | $3.13 Billion | $527.74 Million | ▲ +1.4 pp |
| 2017 | 81.7% | $2.53 Billion | $3.10 Billion | $565.34 Million | ▲ +0.6 pp |
| 2016 | 81.1% | $2.43 Billion | $3.00 Billion | $567.56 Million | ▼ -4.5 pp |
| 2015 | 85.6% | $2.29 Billion | $2.67 Billion | $384.98 Million | — |